APNIMED
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. Sleep apnea is a common, serious condition with significant morbidity, increased mortality, and substantial effects on daily functioning. Sleep apnea affects more than 20 million Americans and has serious consequences. OSA is caused by a combination of predisposing anatomical factors and sleep-related decrements of activity in upper airway muscles. Current treatments primarily rely on positive pressure devices, e.g., CPAP, to maintain airway patency. Less commonly used treatments include mandibular advancement devices, nerve stimulation, and surgical interventions. Apnimed was founded in 2017 and is located in Cambridge, Massachusetts.
APNIMED
Industry:
Health Care Medical Medical Device
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.apnimed.com
Total Employee:
11+
Status:
Active
Total Funding:
207.83 M USD
Technology used in webpage:
Euro CrUX Dataset CrUX Top 5m
Similar Organizations
410 Medical
410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care.
4C Medical Technologies
4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Babson Diagnostics
Babson Diagnostics is a medical technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter.
Exo
Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.
LumiThera
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
Neocis
Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.
Pulmonx
Pulmonx provides minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.
Current Advisors List
Board_member
2022-05-01
Board_member
2022-05-01
Board_member
2022-05-01
Current Employees Featured
Lawrence G. Miller Founder, CEO & Board Chair @ Apnimed
Founder, CEO & Board Chair
2018-01-01
Luigi Taranto Montemurro Co-Founder and Medical Director @ Apnimed
Co-Founder and Medical Director
John Cronin M.D & Senior Vice President of Clinical Development @ Apnimed
M.D & Senior Vice President of Clinical Development
2022-01-01
Michael Rogers Chief Financial Officer @ Apnimed
Chief Financial Officer
2020-01-01
John Yee SVP, Medical Affairs @ Apnimed
SVP, Medical Affairs
2023-01-01
Graham Goodrich Chief Commercial Officer (CCO) @ Apnimed
Chief Commercial Officer (CCO)
2024-01-01
Rob Rode Chief Commercial Officer @ Apnimed
Chief Commercial Officer
2021-09-01
Founder
Investors List
Tao Capital Partners
Tao Capital Partners investment in Series C - Apnimed
Sectoral Asset Management
Sectoral Asset Management investment in Series C - Apnimed
Alpha Wave Global
Alpha Wave Global investment in Series C - Apnimed
Alpha Wave Ventures
Alpha Wave Ventures investment in Series C - Apnimed
Morningside Ventures
Morningside Ventures investment in Series C - Apnimed
Sectoral Asset Management
Sectoral Asset Management investment in Series C - Apnimed
Alpha Wave Global
Alpha Wave Global investment in Series C - Apnimed
Alpha Wave Ventures
Alpha Wave Ventures investment in Series C - Apnimed
Tao Capital Partners
Tao Capital Partners investment in Series C - Apnimed
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Apnimed
Key Employee Changes
Official Site Inspections
http://www.apnimed.com Semrush global rank: 3.26 M Semrush visits lastest month: 4.41 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apnimed"
Who We Are - Apnimed
Jul 3, 2024 The Apnimed Way Just as sleep-related breathing diseases profoundly disrupt lives, we are driven by a shared purpose to disrupt the treatment paradigm to make positive change …See details»
Leadership - Apnimed
Jul 3, 2024 The leadership team represents and upholds the core values that drive all we do at Apnimed. We boldly challenge convention, uplift each other, and foster shared purpose and connection within our walls and beyond them, and …See details»
Apnimed - Crunchbase Company Profile & Funding
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. Sleep apnea is a common, serious condition with …See details»
Apnimed - LinkedIn
Apnimed Pharmaceutical Manufacturing Cambridge, Massachusetts 15,263 followers Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.See details»
Apnimed - Overview, News & Similar companies | ZoomInfo.com
View Apnimed (www.apnimed.com) location in Massachusetts, United States , revenue, industry and description. ... Apnimed has announced that Graham Goodrich has joined the …See details»
Apnimed 2025 Company Profile: Valuation, Funding
When was Apnimed founded? Apnimed was founded in 2017. Where is Apnimed headquartered? Apnimed is headquartered in Cambridge, MA. What is the size of Apnimed? Apnimed has 82 total employees. What industry is Apnimed in? …See details»
Apnimed - Funding, Financials, Valuation & Investors - Crunchbase
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. New. Resources. ... How much funding has this …See details»
Apnimed - Products, Competitors, Financials, Employees, …
About Apnimed Apnimed is a privately held clinical-stage pharmaceutical company dedicated to transforming the treatment landscape for sleep-related breathing diseases. Apnimed envisions …See details»
News at Apnimed
Jul 3, 2024 Apnimed to Host Virtual Investor Event Highlighting the Potential for AD109 as a Novel Pharmacotherapy for Obstructive Sleep Apnea on April 11, 2025. Mar 25, 2025. …See details»
Apnimed, Inc. - Drug pipelines, Patents, Clinical trials
About Apnimed Apnimed is a pharmaceutical company dedicated to breathing new life into the sleep-related breathing disease treatment landscape. The company envisions a new era where novel oral therapies simplify intervention, …See details»
Apnimed - Contacts, Employees, Board Members, Advisors & Alumni
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. ... Experience the new Crunchbase, powered by AI . …See details»
Apnimed Company Profile - Office Locations, Competitors ... - Craft
Apnimed is a pharmaceutical company focused on pharmacologic therapies for obstructive sleep apnea (OSA) and related disorders. Its lead product candidate, AD109, targets key …See details»
Shionogi Announces Further Agreement with Apnimed for Sleep …
10 hours ago For more details, please visit apnimed.com, X, or LinkedIn. About Shionogi-Apnimed Sleep Science, LLC. In November 2023, Shionogi and Apnimed established a joint …See details»
Careers & Culture - Apnimed
Jul 3, 2024 As we build our new Medical Science Liaison (MSL) Team, this group is recognized as a key member of the Apnimed Medical Affairs Organization. The MSLs will focus on …See details»
Apnimed Dawn of a New Era for Obstructive Sleep Apnea: How ...
Apr 11, 2025 Join Apnimed for a virtual investor event featuring key opinion leaders (KOLs) Douglas Kirsch, MD, FAAN, FAASM (Wake Forest University), and Nathaniel Watson, MD, …See details»
Establishment of a Joint Venture Company with Apnimed for …
Nov 1, 2023 The joint venture, Shionogi-Apnimed Sleep Science, LLC, combines Shionogi’s capabilities in small molecule drug discovery and proven ability to create best-in-class …See details»
Apnimed Announces Launch of Joint Venture with Shionogi to
Nov 1, 2023 Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, Mass., the company is …See details»
Apnimed Strengthens Executive Team and Board of Directors with …
“Apnimed is in an excellent position to accelerate into the next stage of corporate development,” noted Mr. Sender. “I am eager to contribute to the financial and strategic initiatives of the …See details»
Apnimed社との睡眠障害領域におけるライセンス契約締結につい …
10 hours ago Apnimed社は、マサチューセッツ州ケンブリッジに拠点を置く睡眠障害における卓越した専門知識を有する製薬企業であり、睡眠時無呼吸症候群（Sleep Apnea …See details»
Keep in Touch With Apnimed
Jul 3, 2024 Apnimed. 39 John F. Kennedy St., 4th Floor Cambridge, MA 02138 1-877-APNIMED (1-877-276-4633) contact@apnimed.com Get directions . Investor RelationsSee details»